Diovan HCT 320-25mg Tablets

Manufacturer NOVARTIS Active Ingredient Valsartan and Hydrochlorothiazide(val SAR tan & hye droe klor oh THYE a zide) Pronunciation val SAR tan & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) and Thiazide Diuretic Combination
🤰
Pregnancy Category
Category D (1st trimester), Category X (2nd and 3rd trimesters)
✅
FDA Approved
Mar 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Diovan HCT is a combination medicine used to treat high blood pressure (hypertension). It contains two active ingredients: valsartan, which is an 'ARB' that helps relax blood vessels, and hydrochlorothiazide, which is a 'water pill' (diuretic) that helps your body get rid of extra salt and water. Together, they help lower your blood pressure, which can reduce your risk of heart attack and stroke.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, and it's best to take it at the same time every day. Continue taking the medication as directed by your doctor or healthcare provider, even if you're feeling well.

It's worth noting that this medication may increase the frequency of urination. To minimize sleep disturbances, try to avoid taking it too close to bedtime. Unless your doctor advises you to limit fluid intake, drink plenty of non-caffeinated liquids to stay hydrated.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. Instead, check with your pharmacist for guidance on the best disposal method or inquire about potential drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take this medication exactly as prescribed, usually once daily with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Continue to follow a low-sodium (low-salt) diet as advised by your doctor or dietitian.
  • Engage in regular physical activity as recommended by your doctor.
  • Limit alcohol intake.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor, as this medication can affect potassium levels.
  • Stay hydrated, especially during hot weather or exercise, but avoid excessive fluid intake unless advised by your doctor.
  • Monitor your blood pressure regularly at home if advised by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One tablet (Valsartan 320 mg / Hydrochlorothiazide 25 mg) once daily
Dose Range: 320 - 25 mg

Condition-Specific Dosing:

hypertension: Initial dose typically lower strengths, titrate up to achieve blood pressure control. 320/25 mg is often a maximum or high-dose combination.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed for CrCl > 30 mL/min.
Moderate: Use with caution. Not recommended for patients with CrCl < 30 mL/min due to hydrochlorothiazide component.
Severe: Contraindicated (CrCl < 30 mL/min or anuria) due to hydrochlorothiazide component.
Dialysis: Not recommended. Valsartan is not significantly removed by hemodialysis. Hydrochlorothiazide is dialyzable but not recommended in severe renal impairment.

Hepatic Impairment:

Mild: No dosage adjustment needed for mild-to-moderate hepatic impairment without cholestasis.
Moderate: Use with caution. Valsartan exposure may be increased. Hydrochlorothiazide should be used with caution as fluid and electrolyte shifts may precipitate hepatic coma.
Severe: Not recommended for severe hepatic impairment or biliary cirrhosis.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Valsartan selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation and reduced sodium and water reabsorption. Hydrochlorothiazide is a thiazide diuretic that inhibits the reabsorption of sodium and chloride ions in the distal convoluted tubule, increasing the excretion of sodium, chloride, and water, and to a lesser extent, potassium and magnesium. This leads to a reduction in plasma volume and peripheral vascular resistance.
📊

Pharmacokinetics

Absorption:

Bioavailability: Valsartan: ~23%; Hydrochlorothiazide: ~50-80%
Tmax: Valsartan: 2-4 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Valsartan: Food decreases AUC by ~48% and Cmax by ~59%, but does not significantly affect therapeutic efficacy. Hydrochlorothiazide: Food has little effect on absorption.

Distribution:

Vd: Valsartan: 17 L; Hydrochlorothiazide: 0.8-1.7 L/kg
ProteinBinding: Valsartan: ~94-97%; Hydrochlorothiazide: ~40-68%
CnssPenetration: Limited

Elimination:

HalfLife: Valsartan: 6-9 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Valsartan: ~2 L/hr; Hydrochlorothiazide: Renal clearance is ~300 mL/min
ExcretionRoute: Valsartan: Feces (83%) and urine (13%); Hydrochlorothiazide: Urine (95% unchanged)
Unchanged: Valsartan: ~13% (urine); Hydrochlorothiazide: ~95% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Valsartan: Within 2 hours; Hydrochlorothiazide: Within 2 hours
PeakEffect: Valsartan: 4-6 hours; Hydrochlorothiazide: 4 hours
DurationOfAction: Valsartan: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Diovan HCT as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Drowsiness
+ Unusual thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Abnormal heartbeat (fast or irregular)
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Feeling extremely tired or weak
+ Decreased appetite
+ Difficulty urinating or changes in urine output
+ Dry mouth
+ Dry eyes
+ Severe nausea or vomiting
Signs of kidney problems, including:
+ Difficulty urinating
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Swelling in the arms or legs
Eye problems, such as changes in vision or eye pain, which can lead to permanent vision loss if left untreated. These symptoms usually occur within hours to weeks of starting the medication.
Rarely, skin cancer has been reported in people taking hydrochlorothiazide. Protect your skin from the sun and follow your doctor's instructions for skin checks. If you notice any changes in the color or size of a mole, or any new or changing skin lump or growth, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:

Dizziness
Headache
Nose or throat irritation

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of low blood pressure: severe dizziness, lightheadedness, fainting.
  • Signs of electrolyte imbalance: unusual muscle weakness, cramps, irregular heartbeat, extreme thirst, confusion.
  • Signs of kidney problems: swelling in feet or ankles, unusual tiredness, dark urine, decreased urination.
  • Signs of allergic reaction: rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, trouble breathing.
  • Signs of eye problems (rare): sudden decrease in vision or eye pain (may indicate acute angle-closure glaucoma, seek immediate medical attention).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any known allergies to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction and its symptoms.
A confirmed sulfa allergy.
Current treatment with dofetilide.
Inability to urinate.
Concurrent use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.
Breast-feeding status, as this medication is not recommended during breast-feeding.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine the safety of taking this medication with your existing treatments and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

To ensure your safety, avoid driving and other activities that require alertness until you understand how this medication affects you. When standing up from a sitting or lying down position, do so slowly to minimize the risk of dizziness or fainting. Be cautious when climbing stairs.

If you have diabetes, it is crucial to monitor your blood sugar levels closely. Additionally, check your blood pressure as directed by your healthcare provider.

Be aware that this medication may cause increased cholesterol and triglyceride levels. If you already have high cholesterol or triglycerides, discuss this with your doctor. Regularly have your blood work and other laboratory tests checked as advised by your doctor, and inform all your healthcare providers and laboratory personnel that you are taking this medication.

It may take several weeks to experience the full effects of this medication. If you are using a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids, consult with your doctor.

Also, talk to your doctor before consuming alcohol, marijuana, or other forms of cannabis, or taking prescription or OTC medications that may cause drowsiness.

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these symptoms may lead to low blood pressure.

If you are taking cholestyramine or colestipol, consult with your pharmacist about the best way to take these medications with this drug. Be aware of the potential for gout attacks.

If you have lupus, this medication may cause your condition to become active or worsen. Immediately inform your doctor if you notice any new or worsening symptoms.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (very low blood pressure)
  • Dizziness
  • Tachycardia (fast heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte disturbances (e.g., hypokalemia, hyponatremia)
  • Dehydration

What to Do:

Call 911 or Poison Control (1-800-222-1222) immediately. Treatment is supportive and symptomatic. Lay the patient supine with legs elevated. Intravenous saline infusion may be given for hypotension. Electrolyte and renal function should be monitored and corrected as needed. Hemodialysis is not effective for valsartan removal but may remove hydrochlorothiazide.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Concomitant use with ACE inhibitors (due to increased risk of hyperkalemia, hypotension, and renal impairment)
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • Lithium
  • NSAIDs (including selective COX-2 inhibitors)
  • Other antihypertensive agents (additive hypotensive effects)
  • Corticosteroids (may antagonize diuretic effect)
  • Digitalis glycosides (increased risk of toxicity with hypokalemia/hypomagnesemia)
  • Non-depolarizing skeletal muscle relaxants (prolonged effect)
🟡

Moderate Interactions

  • Antidiabetic agents (may require dose adjustment)
  • Cholestyramine and colestipol resins (may impair HCTZ absorption)
  • Alcohol, barbiturates, or narcotics (additive orthostatic hypotension)
  • Pressor amines (e.g., norepinephrine, reduced response)
  • Allopurinol (increased risk of hypersensitivity reactions)
  • Amantadine (increased risk of adverse effects)
  • Cytotoxic agents (e.g., cyclophosphamide, methotrexate - increased myelosuppression)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte status, especially potassium due to opposing effects of valsartan (hyperkalemia) and HCTZ (hypokalemia), and to identify hyponatremia, hypomagnesemia, hypercalcemia.

Timing: Prior to initiation

Renal Function (Serum Creatinine, BUN)

Rationale: To assess baseline kidney function and identify potential impairment, as dose adjustments may be needed.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To assess baseline liver function, especially in patients with pre-existing hepatic impairment.

Timing: Prior to initiation

Uric Acid

Rationale: HCTZ can increase uric acid levels.

Timing: Prior to initiation

Blood Glucose

Rationale: HCTZ can affect glucose metabolism.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, as clinically indicated (e.g., weekly after initiation/dose change, then monthly/quarterly)

Target: <130/80 mmHg or individualized target

Action Threshold: Persistent elevation above target; consider dose adjustment or additional therapy.

Serum Electrolytes (Potassium, Sodium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 mEq/L; consider intervention, dose adjustment, or discontinuation.

Renal Function (Serum Creatinine, BUN)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Stable, within patient's baseline

Action Threshold: Significant increase in creatinine (>30% from baseline) or signs of acute kidney injury; consider dose adjustment or discontinuation.

Uric Acid

Frequency: Periodically, especially in patients with history of gout

Target: Within normal limits or individualized target

Action Threshold: Significant elevation or symptoms of gout; consider management.

Blood Glucose

Frequency: Periodically, especially in diabetic patients

Target: Individualized target

Action Threshold: Significant elevation; consider management.

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fainting (syncope)
  • Unusual fatigue or weakness
  • Muscle cramps or weakness (electrolyte imbalance)
  • Nausea or vomiting
  • Dry mouth
  • Increased thirst
  • Swelling of face, lips, tongue, or throat (angioedema - rare but serious)
  • Difficulty breathing
  • Persistent cough
  • Yellowing of skin or eyes (jaundice)
  • Dark urine
  • Severe skin rash or blistering

Special Patient Groups

🤰

Pregnancy

Contraindicated in the 2nd and 3rd trimesters due to significant risk of fetal injury and death. Discontinue as soon as pregnancy is detected. Use in the 1st trimester is also generally avoided due to potential risks.

Trimester-Specific Risks:

First Trimester: Category D. Limited human data, but animal data suggest risk. ARBs are generally avoided. HCTZ is Category B, but combination is D.
Second Trimester: Category X. Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
Third Trimester: Category X. Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
🤱

Lactation

Not recommended. Both valsartan and hydrochlorothiazide are excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., hypotension, hyperkalemia/hypokalemia, effects on renal function), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Risk level L3 (Moderate Concern) - potential for adverse effects on infant due to excretion in milk and potential for affecting milk supply (HCTZ).
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in effectiveness or safety were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses and titrate carefully, monitoring renal function and electrolytes closely due to increased susceptibility to adverse effects and comorbidities.

Clinical Information

💎

Clinical Pearls

  • This combination is typically used when monotherapy with either an ARB or a thiazide diuretic is insufficient to control blood pressure.
  • The 320/25 mg strength is a high dose and usually reserved for patients whose blood pressure is not adequately controlled on lower strengths or other antihypertensive regimens.
  • Monitor for orthostatic hypotension, especially at the start of therapy, with dose increases, or in volume-depleted patients.
  • Patients should be advised to report any signs of angioedema (swelling of face, lips, tongue, throat) immediately.
  • Due to the opposing effects on potassium (valsartan tends to increase, HCTZ tends to decrease), potassium levels may remain relatively stable, but close monitoring is still crucial.
  • Advise patients to avoid sudden changes in position to minimize dizziness.
🔄

Alternative Therapies

  • ACE Inhibitor/Diuretic combinations (e.g., Lisinopril/HCTZ)
  • Calcium Channel Blocker/ARB combinations (e.g., Amlodipine/Valsartan)
  • Beta-blocker/Diuretic combinations
  • Other classes of antihypertensives (e.g., alpha-blockers, direct vasodilators)
  • Monotherapy with an ARB or a thiazide diuretic if appropriate
💰

Cost & Coverage

Average Cost: $100 - $300+ per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic), Tier 3 or higher (for brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to ensure you receive the best possible care.